RNA therapeutics inactivate PCSK9 by inducing a unique intracellular retention form.
about
Oligonucleotide Therapies: The Past and the PresentPhysiological and therapeutic regulation of PCSK9 activity in cardiovascular disease.Selection of DNA aptamers with two modified bases.Prospect and progress of gene therapy in treating atherosclerosis.Hydrogel-Assisted Antisense LNA Gapmer Delivery for In Situ Gene Silencing in Spinal Cord Injury.
P2860
RNA therapeutics inactivate PCSK9 by inducing a unique intracellular retention form.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
RNA therapeutics inactivate PCSK9 by inducing a unique intracellular retention form.
@en
type
label
RNA therapeutics inactivate PCSK9 by inducing a unique intracellular retention form.
@en
prefLabel
RNA therapeutics inactivate PCSK9 by inducing a unique intracellular retention form.
@en
P2093
P50
P1476
RNA therapeutics inactivate PCSK9 by inducing a unique intracellular retention form
@en
P2093
Karin E Lundin
Lilian Larsson
Oscar P B Wiklander
Paolo Parini
P304
P356
10.1016/J.YJMCC.2015.03.009
P577
2015-03-17T00:00:00Z